Source:http://linkedlifedata.com/resource/pubmed/id/15181562
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2004-6-7
|
pubmed:abstractText |
Because milk-borne transmission of human immunodeficiency virus (HIV) diminishes the benefits of perinatal antiviral drug therapy in developing countries, we have developed a new strategy to prevent postnatal and, possibly, intrapartum virus transmission in a primate model. Eight neonatal rhesus macaques were exposed orally to pathogenic simian-human immunodeficiency virus (SHIV); 4 neonates were then given intramuscular postexposure prophylaxis with 3 anti-HIV human neutralizing monoclonal antibodies (nMAbs) with potent cross-clade and cross-group neutralization activity. Untreated infants experienced high viral RNA levels and CD4(+) T-cell losses and died (median survival time, 5.5 weeks). In contrast, all 4 nMAb-treated neonates were protected from infection (P=.028); their plasma, peripheral blood mononuclear cells, and lymph nodes remained virus negative for >1 year. These data are important for designing clinical trials in human neonates and have general implications for AIDS vaccine development, as the epitopes recognized by the 3 nMAbs are conserved among diverse primary isolates.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0022-1899
|
pubmed:author |
pubmed-author:AndersonDaniel CDC,
pubmed-author:BuckleyKathleen AKA,
pubmed-author:FerrantelliFlaviaF,
pubmed-author:KatingerHermannH,
pubmed-author:LiPei-LinPL,
pubmed-author:McClureHarold MHM,
pubmed-author:MontefioriDavid CDC,
pubmed-author:RasmussenRobert ARA,
pubmed-author:RuprechtRuth MRM,
pubmed-author:StieglerGabrielaG,
pubmed-author:WangTaoT
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
189
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2167-73
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:15181562-Administration, Oral,
pubmed-meshheading:15181562-Animals,
pubmed-meshheading:15181562-Antibodies, Monoclonal,
pubmed-meshheading:15181562-Cross Reactions,
pubmed-meshheading:15181562-Disease Models, Animal,
pubmed-meshheading:15181562-HIV Antibodies,
pubmed-meshheading:15181562-HIV Infections,
pubmed-meshheading:15181562-HIV-1,
pubmed-meshheading:15181562-Humans,
pubmed-meshheading:15181562-Immunization, Passive,
pubmed-meshheading:15181562-Infant,
pubmed-meshheading:15181562-Infectious Disease Transmission, Vertical,
pubmed-meshheading:15181562-Macaca mulatta,
pubmed-meshheading:15181562-Neutralization Tests,
pubmed-meshheading:15181562-Simian Acquired Immunodeficiency Syndrome,
pubmed-meshheading:15181562-Simian immunodeficiency virus
|
pubmed:year |
2004
|
pubmed:articleTitle |
Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodies.
|
pubmed:affiliation |
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|